$2B Roundup verdict: A landmark blow to Bayer and a win for health freedom
By willowt // 2025-03-25
Copy
 
  • A Georgia jury ordered Bayer (Monsanto’s parent company) to pay $2.1 billion to a man who claims Roundup weed killer caused his cancer—one of the largest punitive damages in U.S. history.
  • John Barnes, who developed non-Hodgkin’s lymphoma, argued Monsanto knew about Roundup’s cancer risks but hid them. Bayer denies liability, citing global regulatory approvals.
  • The company faces 67,000 pending Roundup lawsuits, having already settled many for $10 billion. This verdict adds pressure amid declining stock prices.
  • The WHO classifies glyphosate (Roundup’s key ingredient) as a "probable carcinogen," but the EPA and others deem it safe—raising concerns about corporate influence on regulators.
  • The case fuels debates on corporate accountability and chemical safety. Bayer may stop U.S. Roundup sales unless legal protections strengthen, while advocates hail the verdict as a victory for public health.
In a stunning legal defeat for corporate agriculture, a Georgia jury has ordered Bayer—parent company of Monsanto—to pay $2.1 billion to a man who claims the company’s Roundup weed killer caused his cancer. This verdict marks one of the largest punitive damages awards in U.S. history and reignites the fierce debate over glyphosate, Roundup’s key ingredient, and its links to cancer.

The case that could reshape corporate accountability

John Barnes, the plaintiff in the case, filed his lawsuit in 2021 after developing non-Hodgkin’s lymphoma, a cancer he attributes to years of Roundup exposure. His legal team argued that Monsanto—acquired by Bayer in 2018—knew about the risks but concealed them from the public. "It's been a long road for him … and he was happy that the truth related to the product (has) been exposed," said Barnes’ attorney, Kyle Findley. "This is another example of Monsanto's refusal to accept responsibility for poisoning people with this toxic product." Bayer, however, maintains that glyphosate is safe, citing regulatory approvals worldwide. In a statement, the company said: "We disagree with the jury’s verdict, as it conflicts with the overwhelming weight of scientific evidence and the consensus of regulatory bodies and their scientific assessments worldwide. We believe that we have strong arguments on appeal to get this verdict overturned." Yet, this isn’t Bayer’s first legal battle—nor its largest. Since acquiring Monsanto, the company has faced over 100,000 lawsuits related to Roundup, settling many for $10 billion while still grappling with 67,000 pending cases.

A history of controversy: From Agent Orange to Roundup

Monsanto’s legacy is marred by controversy. The company was a key producer of Agent Orange, the toxic defoliant used in the Vietnam War, linked to severe health issues in veterans and Vietnamese civilians. Decades later, Roundup—introduced in the 1970s—became the world’s most widely used herbicide, despite mounting evidence of its dangers. In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as a "probable human carcinogen." Yet, the U.S. Environmental Protection Agency (EPA) and other regulators have maintained its safety—a discrepancy that critics argue stems from corporate influence over regulatory agencies.

The future of glyphosate: Will Bayer abandon Roundup?

Bayer’s legal woes have taken a toll. Its stock plummeted 6.6% after the verdict, hitting 2004 lows. Analysts suggest the company may eventually stop selling Roundup in the U.S. unless lawmakers grant stronger legal protections. Goldman Sachs analysts noted that while the Georgia verdict is likely to be reduced on appeal, the case adds pressure on Bayer to resolve litigation. Meanwhile, the company is pinning hopes on a potential U.S. Supreme Court review in 2025, which could limit future lawsuits.

What this means for consumers and health advocates

For natural health advocates, this verdict is a watershed moment. It underscores the power of grassroots legal action against corporate giants—and the urgent need for transparency in chemical safety. As Bayer fights to overturn the ruling, one thing is clear: The battle over glyphosate’s safety is far from over. And for millions who have used Roundup—unknowingly exposed to its risks—justice may finally be within reach. Stay informed. Stay vigilant. Your health freedom depends on it. Sources include: ZeroHedge.com WSJ.com Producer.com
Copy